Goldman Sachs and UBS Warburg will launch Tuesday a $275 million bank deal for RoTech Medical, a subsidiary of Integrated Health Services that markets respiratory products and durable medical equipment. IHS is currently in bankruptcy, but RoTech is being spun out as part of the reorganization, said a banker. Split between a $200 million "B" term loan and a $75 million revolver, the credit already has gathered considerable interest, he added. Leverage is 1.1 times senior and 2.8 times total, with the credit expected to be rated BB-/Ba2, the banker stated. The deal is priced at LIBOR plus 3% on the revolver and LIBOR plus 31/ 2% on the "B" term loan.
March 03, 2002